Tabayag, Violeta S.

HRN: 03-76-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
CEFTRIAXONE 1G (VIAL)
01/11/2025
01/18/2025
IV
2g
Od
Complicated Uti
Waiting Final Action 
01/21/2025
CEFTRIAXONE 1G (VIAL)
01/21/2025
01/27/2025
IV
2g
IV
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: